Janssen-Cilag S.p.A.
14 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag (NCT04567602) | Janssen-Cilag S.p.A. | 2020-10-06 |
| A Study to Describe Routine Treatment Pathways in Participants With Major Depression and Active Suicidal Ideation With Intent in Italy (NCT04463108) | Janssen-Cilag S.p.A. | 2020-06-23 |
| A Study of Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) Psoriasis (NCT04439526) | Janssen-Cilag S.p.A. | 2020-06-10 |
| A Study to Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting (NCT03720561) | Janssen-Cilag S.p.A. | 2018-10-30 |
| An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide Fumarate (NCT03577470) | Janssen-Cilag S.p.A. | 2018-06-13 |
Track Janssen-Cilag S.p.A. automatically
Every clearance here is in the API, with alerts when new ones post.